AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-7.83%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$1.58B
AUM Growth
+$1.58B
(-8.2%)
Cap. Flow
+$81.2M
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
87.3%
Holding
43
New
3
Increased
–
Reduced
2
Closed
3
Top Buys
| 1 |
AST SpaceMobile
ASTS
|
$203M |
| 2 |
MTSR
Metsera, Inc. Common Stock
MTSR
|
$135M |
| 3 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$26.6M |
Top Sells
| 1 |
GitLab
GTLB
|
$158M |
| 2 |
CrowdStrike
CRWD
|
$125M |
| 3 |
BHIL
Benson Hill, Inc.
BHIL
|
$864K |
Sector Composition
| 1 | Technology | 55.05% |
| 2 | Healthcare | 37.76% |
| 3 | Industrials | 7.19% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Freshworks
FRSH
$3.93B
| $229M | 14.5% | 16,206,643 | – | – |
|
2
Arm
ARM
$147B
| $209M | 13.28% | 1,960,784 | – | – |
|
|
3
AST SpaceMobile
ASTS
$13.2B
| $203M | 12.9% | +8,943,486 | New | +$203M |
|
4
Revolution Medicines
RVMD
$7.1B
| $146M | 9.27% | 4,133,277 | – | – |
|
|
MTSR
5
Metsera, Inc. Common Stock
MTSR
$3.71B
| $135M | 8.56% | +4,961,744 | New | +$135M |
|
|
6
GitLab
GTLB
$7.93B
| $128M | 8.12% | 2,724,712 -3,366,526 | -55% | -$158M |
|
7
Planet Labs
PL
$2.15B
| $108M | 6.85% | 31,942,641 | – | – |
|
|
TEM
8
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $74.8M | 4.74% | 1,551,102 | – | – |
|
9
UiPath
PATH
$5.95B
| $72.5M | 4.59% | 7,034,337 | – | – |
|
10
DexCom
DXCM
$29.5B
| $70.8M | 4.49% | 1,036,937 | – | – |
|
|
VERV
11
DELISTED
Verve Therapeutics
VERV
| $56.4M | 3.58% | 12,349,086 | – | – |
|
12
Prime Medicine
PRME
$578M
| $30M | 1.9% | 15,062,498 | – | – |
|
|
MAZE
13
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
| $26.6M | 1.68% | +2,412,471 | New | +$26.6M |
|
|
14
CrowdStrike
CRWD
$106B
| $26.2M | 1.66% | 74,230 -353,665 | -83% | -$125M |
|
15
Monte Rosa Therapeutics
GLUE
$296M
| $6.79M | 0.43% | 1,464,015 | – | – |
|
16
Oscar Health
OSCR
$4.31B
| $6.32M | 0.4% | 481,988 | – | – |
|
17
Beam Therapeutics
BEAM
$1.66B
| $6.28M | 0.4% | 321,604 | – | – |
|
18
Vera Therapeutics
VERA
$1.38B
| $5.8M | 0.37% | 241,264 | – | – |
|
|
DM
19
DELISTED
Desktop Metal, Inc.
DM
| $5.42M | 0.34% | 1,104,871 | – | – |
|
20
Sana Biotechnology
SANA
$777M
| $4.73M | 0.3% | 2,812,500 | – | – |
|
21
Relay Therapeutics
RLAY
$619M
| $4.11M | 0.26% | 1,568,753 | – | – |
|
22
Dianthus Therapeutics
DNTH
$759M
| $3.79M | 0.24% | 208,697 | – | – |
|
23
Lyell Immunopharma
LYEL
$213M
| $3.17M | 0.2% | 5,865,125 | – | – |
|
24
GeneDx Holdings
WGS
$3.72B
| $2.01M | 0.13% | 22,711 | – | – |
|
25
Foghorn Therapeutics
FHTX
$286M
| $1.83M | 0.12% | 500,901 | – | – |
|